Baader Bank Aktiengesellschaft’s Context Therapeutics CNTX Stock Holding History

Baader Bank Aktiengesellschaft’s Portfolio CNTX Stock Details CNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-10,651	Closed	-$4.67K	–	431
2023 Q1	$4.67K	Buy	+10,651	New	+$8.06K	﹤0.01%	360

Other funds holding CNTX

ABG

Ally Bridge Group New York $124M AUM 249.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

MCCA

Mill Creek Capital Advisors Conshohocken, Pennsylvania $4.87B AUM 17.69% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

CHAM

Clear Harbor Asset Management Stamford, Connecticut $1.45B AUM 23.7% 1-Year Est. Return

Baader Bank Aktiengesellschaft's CNTX Position: Q2 2023 in Review

Baader Bank Aktiengesellschaft sold out of Context Therapeutics (CNTX) in Q2 2023, closing a stake of 10,651 shares — an estimated $4.67K sold.

Baader Bank Aktiengesellschaft first reported a position in CNTX in Q1 2023 and held it in 1 quarter. The position peaked at $4.67K in Q1 2023. 22 funds tracked by Wall St. Rank hold CNTX as of Q2 2023.

Baader Bank Aktiengesellschaft reported no remaining Context Therapeutics position as of Q2 2023 after selling out during the quarter.
Baader Bank Aktiengesellschaft sold 10,651 Context Therapeutics shares in Q2 2023, an estimated $4.67K.
Baader Bank Aktiengesellschaft first reported a position in Context Therapeutics in Q1 2023 and held it in 1 quarter.
Baader Bank Aktiengesellschaft's Context Therapeutics position peaked at $4.67K in Q1 2023.
22 funds tracked by Wall St. Rank held Context Therapeutics as of Q2 2023.

Based on Baader Bank Aktiengesellschaft's 13F filing for Q2 2023, filed 11 Aug 2023.